Sagespring Wealth Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$933K Sell
11,922
-24,405
-67% -$1.97M 0.01% 365
2026
Q1
$3.15M Buy
36,327
+4,410
+14% +$422K 0.06% 154
2025
Q4
$3.07M Buy
31,917
+2,531
+9% +$246K 0.06% 151
2025
Q3
$2.8M Buy
29,386
+5,008
+21% +$460K 0.05% 150
2025
Q2
$2.13M Buy
24,378
+1,900
+8% +$161K 0.05% 167
2025
Q1
$2.02M Buy
22,478
+4,794
+27% +$429K 0.05% 155
2024
Q4
$1.41M Buy
+17,684
New +$1.53M 0.04% 175

Other funds holding MDT

Sagespring Wealth Partners's MDT Position: Q2 2026 in Review

Sagespring Wealth Partners reduced its Medtronic (MDT) stake by 67% in Q2 2026, selling an estimated $1.97M and leaving 11,922 shares worth $933K. The position accounts for 0.01% of the portfolio, ranked #365.

Sagespring Wealth Partners first reported a position in MDT in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.15M in Q1 2026. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Sagespring Wealth Partners held 11,922 shares of Medtronic worth $933K as of Q2 2026.
  • Sagespring Wealth Partners sold 24,405 Medtronic shares in Q2 2026, an estimated $1.97M.
  • Medtronic made up 0.01% of Sagespring Wealth Partners's portfolio in Q2 2026, its #365 holding.
  • Sagespring Wealth Partners first reported a position in Medtronic in Q4 2024 and has held it in 7 quarters since.
  • Sagespring Wealth Partners's Medtronic position peaked at $3.15M in Q1 2026.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.